Pharmaron · 1 day ago
Intern – Immunoassay
Pharmaron is a global CRO helping pharma and biotech companies bring new therapies to life. This internship offers hands-on experience in large molecule bioanalysis within a regulated laboratory setting, supporting bioanalytical workflows and gaining foundational knowledge of immunoassay techniques critical to the drug development process.
BiotechnologyChemicalPharmaceutical
Responsibilities
Perform large molecule bioanalytical assays using various platforms, primarily ELISA and ECL (Electrochemiluminescence – MSD), under supervision
Prepare reagents, solutions, and standards in accordance with bioanalytical procedures and SOPs, with appropriate documentation
Accurately pipette samples and execute immunoassay procedures following established protocols
Utilize data analysis software (e.g., SoftMax Pro, Watson LIMS) to assist with processing assay data, including evaluation of standard curves and QC criteria
Understand and comply with all applicable safety procedures and contribute to maintaining a clean and safe laboratory environment
Collaborate with laboratory staff and scientists to support ongoing projects
Perform additional duties as assigned that are consistent with skill level and training
Qualification
Required
Currently pursuing or recently completed a Bachelor's or Master's degree in Biology, Biochemistry, Biotechnology, Pharmaceutical Sciences, or a related scientific field
Prior laboratory coursework, academic research, or internship experience preferred
Strong attention to detail and ability to follow written procedures
Willingness to learn and work in a regulated laboratory environment
Preferred
Exposure to immunoassay techniques such as ELISA, Western Blot, or enzyme-based assays
Familiarity with laboratory data systems (e.g., Watson™ LIMS)
Awareness of FDA and ICH bioanalytical method validation guidelines
Exposure to LC-MS/MS or other bioanalytical platforms
Company
Pharmaron
Pharmaron is a contract research organization that offers research and development services for the life science industries.
Funding
Current Stage
Public CompanyTotal Funding
$907.82MKey Investors
GL Capital
2019-11-22Post Ipo Equity· $587.82M
2019-01-28IPO
2015-12-14Series Unknown· $280M
Recent News
Precedence Research
2025-11-07
Business Wire
2025-10-29
Company data provided by crunchbase